Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Genus (Animal Genetic)

Genus (Animal Genetic)
1994 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
GNS STOCK SYMBOL
5 INVESTMENTS
$40.79 SHARE PRICE (As of Friday Closing)
Description

Genus is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. The company generates most of its revenue from its porcine exposure, followed by its bovine exposure. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Animal Husbandry
Stock Exchange
LON
Primary Office
  • Matrix House
  • Basing View
  • Basingstoke RG21 4DZ
  • England, United Kingdom

+44 01256 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Genus (Animal Genetic)’s full profile, request a free trial.

Genus (Animal Genetic) Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$27.04 - $41.89 $2.65B $41.16 $0.16 88.1K 65.1M

Genus (Animal Genetic) Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 2,294,145 2,294,145 2,279,723 1,546,075
Revenue 632,166 632,166 632,898 582,215
EBITDA 52,152 52,152 48,715 66,959
Net Income 10,094 10,094 57,463 41,596
Total Assets 1,044,368 1,044,368 1,031,796 1,037,690
Total Debt 139,528 139,528 179,898 179,670
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genus (Animal Genetic) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Genus (Animal Genetic)‘s full profile, request access.

Request full access to PitchBook

Genus (Animal Genetic) Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 23-Feb-2017 000000000000000000 Animal Husbandry 00000 00000
00 00000 000000 01-Apr-2015 000000000000000000 00.000 Biotechnology 00000 00000
0000000000 0000000 23-Sep-2013 000000000000000000 0000 Other Commercial Services 00000 00000
000 000000 10-Dec-1999 000000000000000000 Animal Husbandry
Animalcare Group 01-Jan-1999 Merger/Acquisition Holding Companies
To view this company’s complete investment and acquisition history, request access »

Genus (Animal Genetic) Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 00000 01-Jan-1999 000000000000000000 Completed
  • 00000 (000000 0000
To view this company’s complete exits history, request access »

Genus (Animal Genetic) Subsidiaries (3)

Company Name Industry Location Founded
In Vitro Brasil Biotechnology Mogi Mirim, Brazil 2002
000000000 Animal Husbandry Kilkenny, Ireland 0000
000 000000 Animal Husbandry DeForest, WI 0000
To view this company’s complete subsidiary history, request access »

Genus (Animal Genetic) Executive Team (4)

Name Title Board
Seat
Contact
Info
Stephen Wilson Chief Executive Officer & Board Member
Jonathan Lightner Chief R&D and Scientific Officer

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »

Genus (Animal Genetic) Board Members (3)

Name Representing Role Since Contact
Info
000000 000000 Self Chairman & Board Member 000 0000
0000000 000000 Genus (Animal Genetic) Chief Executive Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »